Patient.info PatientProfessionalArticle https://patient.info/doctor/rss Latest updates from Patient.info PatientProfessionalArticle Copyright 2026 Patient.info 413 - Primary Care Bulletin: NHS Updates from 5 November 2026 Thomas Andrew Porteus, MBCS https://patient.info/doctor/nhs-bulletin/413 1Mcpf8SM4CDABtwfbujw2o 2026-11-05T16:52:54.000Z Duvyzat®▼ (givinostat): interim advice on risk mitigation measures following reports of deaths in patients while taking givinostat Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/duvyzat-r-v-givinostat-interim-advice-on-risk-mitigation-measures-following-reports-of-deaths-in-patients-while-taking-givinostat 49UPhtsFoxsglvZKdV7aPH 2026-11-05T12:00:11.000Z Class 3 Medicines Recall: Aspire Pharma Limited, Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml , EL(26)A/47 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/class-3-medicines-recall-aspire-pharma-limited-tropicamide-1-percent-eye-drops-solution-in-single-dose-containers-20-x-0-dot-5ml-el-26-a-slash-47 1Vz310n9hueYG9JzKvFY99 2026-11-05T11:00:55.000Z Class 4 Medicines Defect Notification: Sandoz Limited, Co-Amoxiclav powder for oral suspension 250/62.5 mg/mL, EL(26)A/46 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/class-4-medicines-defect-notification-sandoz-limited-co-amoxiclav-powder-for-oral-suspension-250-slash-62-dot-5-mg-slash-ml-el-26-a-slash-46 7b2zJ5G2XYeutV32eAkCum 2026-11-05T10:00:07.000Z Field Safety Notices: 26 to 30 October 2026 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/field-safety-notices-26-to-30-october-2026 7tczU4AQ7X2C9dGS4EZOpb 2026-11-04T12:22:28.000Z Influenza vaccination https://patient.info/doctor/drug-therapy/influenza-vaccination doc_342 2026-11-01T23:00:00.000Z 412 - Primary Care Bulletin: NHS Updates from 29 October 2026 Thomas Andrew Porteus, MBCS https://patient.info/doctor/nhs-bulletin/412 2TBq8arlOkOpLeXmzAAWNG 2026-10-29T16:58:59.000Z Class 2 Medicines Recall: Accord-UK Ltd, Lercanidipine Hydrochloride 10mg Film-Coated Tablets, EL(26)A/45 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/class-2-medicines-recall-accord-uk-ltd-lercanidipine-hydrochloride-10mg-film-coated-tablets-el-26-a-slash-45 4fBiLRmJ8mArLgWzMFBthz 2026-10-29T13:59:33.000Z Class 2 Medicines Recall: Advanz Pharma Limited, Mynzepli 40 mg/mL solution for injection in pre-filled syringe, EL(26)A/44 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/class-2-medicines-recall-advanz-pharma-limited-mynzepli-40-mg-slash-ml-solution-for-injection-in-pre-filled-syringe-el-26-a-slash-44 3HDM7L4AGrOW715IEoPIOr 2026-10-29T10:00:21.000Z Field Safety Notices: 19 to 23 October 2026 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/field-safety-notices-19-to-23-october-2026 2hFVUM181vT7eptf1fvF8M 2026-10-28T13:23:46.000Z